Hachiya, A., Marchand, B., Kirby, K. A., Michailidis, E., Tu, X., Palczewski, K., . . . Sarafianos, S. G. (2012). HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors. American Society for Biochemistry and Molecular Biology.
Citação norma ChicagoHachiya, Atsuko, et al. HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors. American Society for Biochemistry and Molecular Biology, 2012.
MLA citiranjeHachiya, Atsuko, et al. HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors. American Society for Biochemistry and Molecular Biology, 2012.